Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2010 2
2011 1
2012 1
2013 1
2016 1
2017 2
2019 1
2020 1
2021 1
2022 2
2023 3
2024 5
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 Inhibitors from Nigella Sativa.
Baig A, Srinivasan H. Baig A, et al. Appl Biochem Biotechnol. 2022 Mar;194(3):1051-1090. doi: 10.1007/s12010-021-03790-8. Epub 2022 Feb 1. Appl Biochem Biotechnol. 2022. PMID: 35102539 Free PMC article.
Efficacy of albumin use in decompensated cirrhosis and real-world adoption in Australia.
Kalo E, Read S, Baig A, Marshall K, Ma WS, Crowther H, Gofton C, Lynch KD, Sood S, Holmes J, Lubel J, Wigg A, McCaughan G, Roberts SK, Caraceni P, Ahlenstiel G, Majumdar A. Kalo E, et al. Among authors: baig a. JGH Open. 2024 Sep 18;8(9):e70029. doi: 10.1002/jgh3.70029. eCollection 2024 Sep. JGH Open. 2024. PMID: 39301299 Free PMC article. Review.
A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The A ustra l ian L iver F a i lur e (ALFIE) trial.
Wigg AJ, Narayana S, Woodman RJ, Adams LA, Wundke R, Chinnaratha MA, Chen B, Jeffrey G, Plummer JL, Sheehan V, Tse E, Morgan J, Huynh D, Milner M, Stewart J, Ahlensteil G, Baig A, Kaambwa B, Muller K, Ramachandran J. Wigg AJ, et al. Among authors: baig a. Hepatology. 2025 Jan 1;81(1):136-151. doi: 10.1097/HEP.0000000000000862. Epub 2024 Mar 27. Hepatology. 2025. PMID: 38825975 Clinical Trial.
HCV elimination: is the bulk of the iceberg being missed?
Kalo E, Baig A, Derrett A, Read S, Ahlenstiel G. Kalo E, et al. Among authors: baig a. Gastroenterol Rep (Oxf). 2024 Oct 15;12:goae093. doi: 10.1093/gastro/goae093. eCollection 2024. Gastroenterol Rep (Oxf). 2024. PMID: 39411102 Free PMC article. No abstract available.
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug design.
O'Brien A, Andrews SP, Baig AH, Bortolato A, Brown AJH, Brown GA, Brown SH, Christopher JA, Congreve M, Cooke RM, De Graaf C, Errey JC, Fieldhouse C, Jazayeri A, Marshall FH, Mason JS, Mobarec JC, Okrasa K, Steele KN, Southall SM, Teobald I, Watson SP, Weir M. O'Brien A, et al. Among authors: baig ah. Bioorg Med Chem Lett. 2019 Oct 15;29(20):126611. doi: 10.1016/j.bmcl.2019.08.015. Epub 2019 Aug 9. Bioorg Med Chem Lett. 2019. PMID: 31447084
Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities.
Audouze K, Zgheib E, Abass K, Baig AH, Forner-Piquer I, Holbech H, Knapen D, Leonards PEG, Lupu DI, Palaniswamy S, Rautio A, Sapounidou M, Martin OV. Audouze K, et al. Among authors: baig ah. Front Toxicol. 2021 Dec 21;3:787017. doi: 10.3389/ftox.2021.787017. eCollection 2021. Front Toxicol. 2021. PMID: 35295112 Free PMC article. No abstract available.
21 results